Fosun International Ltd 13D and 13G filings for Amneal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-24 06:03 am Sale |
2024-03-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
Fosun International Ltd | 9,200,603 3.000% |
-9,207,053 (-50.02%) |
Filing |
| 2023-12-12 06:04 am Unchanged |
2023-11-07 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
Fosun International Ltd | 18,407,656 6.000% |
0 (Unchanged) |
Filing |